May 15, 2017
Researchers quantify risks associated with common MS drug
Dr. Helen Tremlett, Canada Research Chair in Neuroepidemiology and Multiple Sclerosis, and her research...
Dr. Helen Tremlett, Canada Research Chair in Neuroepidemiology and Multiple Sclerosis, and her research...
Working with a shared voice can be very effective for improving outcomes in the...
New research from Dr. Helen Tremlett, Canada Research Chair in Neuroepidemiology and Multiple Sclerosis...
Less than a year after publishing research identifying a single genetic mutation that caused...
By the time a person with Parkinson’s disease (PD) receives a diagnosis, they have...
A simple compound is showing promise in limiting disease progression in multiple sclerosis (MS),...
In recognition of the challenges faced by British Columbians with Parkinson’s disease, the Ministry...
On the first floor of the Djavad Mowafaghian Centre for Brain Health, a massive,...
New research from MSFHR trainee Dr. Jose Wijnands, a member of Dr. Helen Tremlett’s Pharmacoepidemiology in Multiple Sclerosis Research...
Habitual exercise may confer an advantage in combating Parkinson’s disease by facilitating the brain’s...
Pictured left: MRI image showing the fusion of a vein scan and a lesion scan. the...
Diseases of the brain are different from other diseases in that there just isn’t...